RARE DISEASE COMPANY COALITION

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

8 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $550,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. Everything on this page is grouped by the registrant's LDA id (401109501), not by name.

Clients 1

RARE DISEASE COMPANY COALITION $550,000 8 filings

Lobbyists named 2

GABBI SALMON 1 filing · through 2026 Legislative Intern, Sen. Lamar Alexander.
YOKO ROSENBAUM 1 filing · through 2025 Intern, United States House of Representatives

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $260,000 3 filings
2025 $290,000 5 filings

Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 7
SENATE 7
Centers For Medicare and Medicaid Services (CMS) 1
Food & Drug Administration (FDA) 1
U.S. Trade Representative (USTR) 1
White House Office 1

Recent filings 8 total

Q3 report

RARE DISEASE COMPANY COALITION

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 expenses · posted Oct 15, 2026

View → Q2 report

RARE DISEASE COMPANY COALITION

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 expenses · posted Jul 16, 2026

View → Q1 report

RARE DISEASE COMPANY COALITION

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $110,000 expenses · posted Apr 20, 2026

View → Q4 report

RARE DISEASE COMPANY COALITION

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $70,000 expenses · posted Jan 20, 2026

View → Q3 report

RARE DISEASE COMPANY COALITION

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $90,000 expenses · posted Oct 16, 2025

View → Q2 report

RARE DISEASE COMPANY COALITION

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $70,000 expenses · posted Jul 18, 2025

View → Q1 amendment

RARE DISEASE COMPANY COALITION

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $60,000 expenses · posted Apr 21, 2025

View → Registration

RARE DISEASE COMPANY COALITION

1st Quarter 2025 (Jan 1 - Mar 31) · posted Apr 18, 2025

View →

Keep going

Filings through October 15, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.